Adamas One Receives Nasdaq Notification of Non-Compliance globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Kazia Therapeutics Limited (NASDAQ: KZIA) (Kazia or the company) received a letter on May 22, 2024 from Nasdaq notifying the Company that,.
The Board has Approved a Ratio Change of the ADSs to Non-traded Ordinary Shares Designed to Regain Compliance JERUSALEM, ISRAEL -May 6th, 2024 - Scinai.
Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. As previously disclosed, on February 27, 2024, Twelve Seas.
Eagle Pharmaceuticals Announces Receipt of Delisting Notification from Nasdaq tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.